پمپ جدید کمپانی Unilife بسیار راحت به پوست وصل میشود و به راحتی قابلیت استفاده تا چند روز را دارد.
این پمپ از قبل پر شده با انسولین میباشد و به راحتی قابل برنامه ریزی برای تزریق انسولین بصورت پایه و تزریق لحظه ای یا بولوس برحسب نیاز شما میباشد.
این دستگاه قابلیت کار با سیستم ارتباطی Bluetooth جهت ارسال یادآور به گوشی هوشمند شما را دارد.
متن زیر مطلب کامل در این باره است:
Unilife Introduces World’s First Instant Patch Pump for Insulin
Thursday, July 30 at 8:30 a.m. EDT
YORK, Pa., July 29, 2015 /PRNewswire/ —
Unilife Corporation (NASDAQ: UNIS and ASX: UNS), a developer, manufacturer and supplier of injectable drug delivery systems, today announced the introduction of the Imperium™ platform of instant patch pumps for insulin.
Imperium is a prefilled, disposable, multi-day wearable insulin pump that does not require filling or assembly by the patient. Because it is prefilled and pre-assembled like an insulin pen, only three intuitive steps are required to commence continuous subcutaneous insulin infusion, with on-demand bolus delivery available to the user via the simple push of a button. Imperium can include wireless connectivity systems, such as Bluetooth LE, to integrate with smartphone apps for patient reminders and status updates. With data connectivity available, healthcare providers could also have access to real-time or historic data to tailor the insulin therapy for each patient to achieve and maintain glycemic control.
Imperium is designed for supply to a select insulin partner or partners ready for filling and packaging using standard pharmaceutical processes, materials and equipment. Insulin partners can then sell the prefilled, fully-assembled device through existing commercial channels, with no sales, marketing, commercial development, reimbursement, and clinical support costs to Unilife. As a prefilled, high-precision device with a delivery resolution of 0.5µL, Imperium is suitable for use with high concentration insulins up to U-500.
Mr. Alan Shortall, Chairman and Chief Executive Officer of Unilife, said: “Imperium combines the therapeutic advantages of a pump with the low cost and convenience of a prefilled, disposable pen. By addressing specific unmet market needs and creating value for all diabetes stakeholders, it is set to empower millions of insulin-dependent patients to achieve and maintain glycemic control.”
“Unlike with traditional pumps or patch pumps, Imperium is designed to allow a selected insulin partner or partners to supply a complete basal-bolus insulin therapy directly to the patient under a single prescription at a price that is as attractive for reimbursement as prefilled pens. As a compact, ready-to-use and fully integrated insulin system requiring minimal steps for convenient, multi-day wear, it is well positioned to help improve patient adherence and generate positive healthcare outcomes.”
“In recognition of Imperium’s potential to penetrate large, growing markets, including Type 2 diabetes, that remain under-served due to device complexity, reimbursement constraints and high out-of-pocket-cost for patients, we expect to enter into a collaboration agreement with one or more interested parties that will support its long-term commercial supply with specific brands of insulin.”
The Company has scheduled a conference call for 8:30 a.m. U.S. EDT on Thursday, July 30, 2015 (Thursday, July 30, 2015, at 10:30 p.m. AEST), to update shareholders on its business activities and introduce the Imperium™ platform of instant insulin patch pumps.
The conference call and accompanying slide presentation will be broadcast over the Internet as a “live” listen-only Webcast. An archive of the presentation and webcast will be available for 30 days after the call. To listen, please go to: http://ir.unilife.com/events.cfm
A short video introducing Imperium is available on the Unilife website at www.unilife.com
SOURCE Unilife CorporationRELATED LINKS